<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33378537</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>24</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>25</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice.</ArticleTitle><Pagination><StartPage>3900</StartPage><EndPage>3918</EndPage><MedlinePgn>3900-3918</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddaa279</ELocationID><Abstract><AbstractText>C9orf72 ALS/FTD patients show remarkable clinical heterogeneity, but the complex biology of the repeat expansion mutation has limited our understanding of the disease. BAC transgenic mice were used to better understand the molecular mechanisms and repeat length effects of C9orf72 ALS/FTD. Genetic analyses of these mice demonstrate that the BAC transgene and not integration site effects cause ALS/FTD phenotypes. Transcriptomic changes in cell proliferation, inflammation and neuronal pathways are found late in disease and alternative splicing changes provide early molecular markers that worsen with disease progression. Isogenic sublines of mice with 800, 500 or 50 G4C2 repeats generated from the single-copy C9-500 line show longer repeats result in earlier onset, increased disease penetrance and increased levels of RNA foci and dipeptide RAN protein aggregates. These data demonstrate G4C2 repeat length is an important driver of disease and identify alternative splicing changes as early biomarkers of C9orf72 ALS/FTD.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pattamatta</LastName><ForeName>Amrutha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Lien</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olafson</LastName><ForeName>Hailey R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotti</LastName><ForeName>Marina M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laboissonniere</LastName><ForeName>Lauren A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berglund</LastName><ForeName>J Andrew</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RNA Institute and Department of Biological Sciences, University at Albany, Albany, NY 12222, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Eric T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranum</LastName><ForeName>Laura P W</ForeName><Initials>LPW</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Colllege of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fixel Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS098819</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017398" MajorTopicYN="Y">Alternative Splicing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="Y">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019683" MajorTopicYN="Y">Penetrance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>30</Day><Hour>17</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33378537</ArticleId><ArticleId IdType="pmc">PMC7906756</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddaa279</ArticleId><ArticleId IdType="pii">6055788</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J. &#xa0;et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72, 245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Laaksovirta, H., van &#xa0;Swieten, J.C., Myllykangas, L. &#xa0;et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72, 257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash, P.E., Bieniek, K.F., Gendron, T.F., Caulfield, T., Lin, W.L., Dejesus-Hernandez, M., van &#xa0;Blitterswijk, M.M., Jansen-West, K., Paul, J.W., 3rd, Rademakers, R. &#xa0;et al. (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron, 77, 639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio, A., Restagno, G., Brunetti, M., Ossola, I., Calvo, A., Canosa, A., Moglia, C., Floris, G., Tacconi, P., Marrosu, F. &#xa0;et al. (2012) ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations. J. Neurol. Neurosurg. Psychiatry, 83, 730&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568835</ArticleId><ArticleId IdType="pubmed">22550220</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck, I., Van Langenhove, T., van der &#xa0;Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., Janssens, J., Bettens, K., Van Cauwenberghe, C., Pereson, S. &#xa0;et al. (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol., 11, 54&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori, K., Weng, S.M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H.A., Cruts, M., Van Broeckhoven, C. &#xa0;et al. (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science, 339, 1335&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart, H., Rutherford, N.J., Briemberg, H., Krieger, C., Cashman, N., Fabros, M., Baker, M., Fok, A., DeJesus-Hernandez, M., Eisen, A. &#xa0;et al. (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol., 123, 409&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3322555</ArticleId><ArticleId IdType="pubmed">22228244</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove, T., van der &#xa0;Zee, J., Gijselinck, I., Engelborghs, S., Vandenberghe, R., Vandenbulcke, M., De Bleecker, J., Sieben, A., Versijpt, J., Ivanoiu, A. &#xa0;et al. (2013) Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. JAMA Neurol., 70, 365&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">23338682</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde, S., van der &#xa0;Zee, J., Gijselinck, I., Sleegers, K., De Bleecker, J., Sieben, A., Vandenberghe, R., Van Langenhove, T., Baets, J., Deryck, O. &#xa0;et al. (2017) Clinical evidence of disease anticipation in families segregating a C9orf72 repeat expansion. JAMA Neurol., 74, 445&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">28192553</ArticleId></ArticleIdList></Reference><Reference><Citation>van der &#xa0;Zee, J., Gijselinck, I., Dillen, L., Van Langenhove, T., Theuns, J., Engelborghs, S., Philtjens, S., Vandenbulcke, M., Sleegers, K., Sieben, A. &#xa0;et al. (2013) A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum. Mutat., 34, 363&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638346</ArticleId><ArticleId IdType="pubmed">23111906</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu, T., Liu, Y., Banez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., Miller, T.M., Harms, M.B., Falchook, A.E., Subramony, S.H. &#xa0;et al. (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U. S. A., 110, E4968&#x2013;E4977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, L., Cleary, J.D. and Ranum, L.P.W. (2019) Repeat-associated non-ATG translation: molecular mechanisms and contribution to neurological disease. Annu. Rev. Neurosci., 42, 227&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687071</ArticleId><ArticleId IdType="pubmed">30909783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao, Z.B., Liu, L., Tao, Z.T., Wang, R., Ren, H.G., Sun, H.Y., Lin, Z.X., Zhang, Z.X., Mu, C.C., Zhou, J.W. &#xa0;et al. (2019) Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat. Commun., 10, 2906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y.J., Guo, L., Gonzales, P.K., Gendron, T.F., Wu, Y.W., Jansen-West, K., O'Raw, A.D., Pickles, S.R., Prudencio, M., Carlomagno, Y. &#xa0;et al. (2019) Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science, 363, 707 &#xa0;-+.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio, A., Decman, V., White, D., Ramos, M., Ikiz, B., Lee, H.C., Siao, C.J., Brydges, S., LaRosa, E., Bai, Y. &#xa0;et al. (2016) C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep., 6, 23204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry, A., Suzuki, N., Wang, J.Y., Moccia, R., Mordes, D.A., Stewart, M.H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F.T. &#xa0;et al. (2016) Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med., 8, 347ra393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew, J., Gendron, T.F., Prudencio, M., Sasaguri, H., Zhang, Y.J., Castanedes-Casey, M., Lee, C.W., Jansen-West, K., Kurti, A., Murray, M.E. &#xa0;et al. (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science, 348, 1151&#x2013;1154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, J., Zhu, Q., Gendron, T.F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J.E., Jafar-Nejad, P., Drenner, K., Schulte, D. &#xa0;et al. (2016) Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron, 90, 535&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Pattamatta, A., Zu, T., Reid, T., Bardhi, O., Borchelt, D.R., Yachnis, A.T. and Ranum, L.P. (2016) C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron, 90, 521&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke, J.G., Bogdanik, L., Muhammad, A.K., Gendron, T.F., Kim, K.J., Austin, A., Cady, J., Liu, E.Y., Zarrow, J., Grant, S. &#xa0;et al. (2015) C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron, 88, 892&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, O.M., Cabrera, G.T., Tran, H., Gendron, T.F., McKeon, J.E., Metterville, J., Weiss, A., Wightman, N., Salameh, J., Kim, J. &#xa0;et al. (2015) Human C9ORF72 Hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not Neurodegeneration in BAC transgenic mice. Neuron, 88, 902&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi, M.H., Becker, L., Garrett, L., Gendron, T.F., Zhou, Q., Schreiber, F., Popper, B., Dimou, L., Strom, T.M., Winkelmann, J. &#xa0;et al. (2017) Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol., 134, 241&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y.J., Gendron, T.F., Ebbert, M.T.W., O'Raw, A.D., Yue, M., Jansen-West, K., Zhang, X., Prudencio, M., Chew, J., Cook, C.N. &#xa0;et al. (2018) Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med., 24, 1136&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite, A.J., Baumer, D., East, S., Neal, J., Morris, H.R., Ansorge, O. and Blake, D.J. (2014) Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging, 35, 1779 e1775&#x2013;1779 e1713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska, S., Gronke, S., Niccoli, T., Ridler, C.E., Clayton, E.L., Devoy, A., Moens, T., Norona, F.E., Woollacott, I.O.C., Pietrzyk, J. &#xa0;et al. (2014) C9orf72 repeat expansions cause neurodegeneration in drosophila through arginine-rich proteins. Science, 345, 1192&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly, C.J., Zhang, P.W., Pham, J.T., Heusler, A.R., Mistry, N.A., Vidensky, S., Daley, E.L., Poth, E.M., Hoover, B., Fines, D.M. &#xa0;et al. (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron, 80, 415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio, M., Belzil, V.V., Batra, R., Ross, C.A., Gendron, T.F., Pregent, L.J., Murray, M.E., Overstreet, K.K., Piazza-Johnston, A.E., Desaro, P. &#xa0;et al. (2015) Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci., 18, 1175&#x2013;1182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbert, M.T.W., Ross, C.A., Pregent, L.J., Lank, R.J., Zhang, C., Katzman, R.B., Jansen-West, K., Song, Y.P., da &#xa0;Rocha, E.L., Palmucci, C. &#xa0;et al. (2017) Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72-associated and sporadic ALS, and implicates SERPINA1 in disease. Acta Neuropathol., 134, 715&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5647251</ArticleId><ArticleId IdType="pubmed">28808785</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock, J., Walsh, M.J., Higginbottom, A., Robin Highley, J., Dickman, M.J., Edbauer, D., Ince, P.G., Wharton, S.B., Wilson, S.A., Kirby, J. &#xa0;et al. (2014) Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain, 137, 2040&#x2013;2051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum, B.D., Lu, Y., Lopez-Gonzalez, R., Kim, N.C., Almeida, S., Lee, K.H., Badders, N., Valentine, M., Miller, B.L., Wong, P.C. &#xa0;et al. (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature, 525, 129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler, A.R., Donnelly, C.J., Periz, G., Simko, E.A., Shaw, P.G., Kim, M.S., Maragakis, N.J., Troncoso, J.C., Pandey, A., Sattler, R. &#xa0;et al. (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature, 507, 195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S.B., Paul, J.W., 3rd, Sun, S., Herdy, J.R., Bieri, G. &#xa0;et al. (2015) Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci., 18, 1226&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, Y.B., Chen, H.J., Peres, J.N., Gomez-Deza, J., Attig, J., Stalekar, M., Troakes, C., Nishimura, A.L., Scotter, E.L., Vance, C. &#xa0;et al. (2013) Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep., 5, 1178&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen, D., O'Rourke, J.G., Meera, P., Muhammad, A.K., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A. &#xa0;et al. (2013) Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med., 5, 208ra149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Z., Poidevin, M., Li, X., Li, Y., Shu, L., Nelson, D.L., Li, H., Hales, C.M., Gearing, M., Wingo, T.S. &#xa0;et al. (2013) Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl. Acad. Sci. U. S. A., 110, 7778&#x2013;7783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, K., Donnelly, C.J., Haeusler, A.R., Grima, J.C., Machamer, J.B., Steinwald, P., Daley, E.L., Miller, S.J., Cunningham, K.M., Vidensky, S. &#xa0;et al. (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature, 525, 56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon, E.G., Lu, L., Sharma, A., Yamazaki, T., Tang, T., Shneider, N.A. and Manley, J.L. (2016) The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife, 5, e17820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, J.P., Brown, R.H., Jr. and Cleveland, D.W. (2016) Decoding ALS: from genes to mechanism. Nature, 539, 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie, E., Renton, A.E., Mok, K., Dopper, E.G., Waite, A., Rollinson, S., Chio, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J. &#xa0;et al. (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol., 11, 323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, N.A., Arthur, K.C., Tienari, P.J., Houlden, H., Chio, A. and Traynor, B.J. (2017) Age-related penetrance of the C9orf72 repeat expansion. Sci. Rep., 7, 2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5437033</ArticleId><ArticleId IdType="pubmed">28522837</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, L., Houlden, H. and Tabrizi, S.J. (2017) DNA repair in the trinucleotide repeat disorders. Lancet Neurol., 16, 88&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">27979358</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J.M., Wheeler, V.C., Chao, M.J., Vonsattel, J.P.G., Pinto, R.M., Lucente, D., Abu-Elneel, K., Ramos, E.M., Mysore, J.S., Gillis, T. &#xa0;et al. (2015) Identification of genetic factors that modify clinical onset of Huntington's disease. Cell, 162, 516&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524551</ArticleId><ArticleId IdType="pubmed">26232222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright, G.E.B., Collins, J.A., Kay, C., McDonald, C., Dolzhenko, E., Xia, Q.W., Becanovic, K., Drogemoller, B.I., Semaka, A., Nguyen, C.M. &#xa0;et al. (2019) Length of uninterrupted CAG, independent of Polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease. Am. J. Hum. Genet., 104, 1116&#x2013;1126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6556907</ArticleId><ArticleId IdType="pubmed">31104771</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde, S., van der &#xa0;Zee, J., Cruts, M. and Van Broeckhoven, C. (2017) Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev., 44, 117&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">28319737</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung, G.Y., DeJesus-Hernandez, M., Feldman, H.H., Sengdy, P., Bouchard-Kerr, P., Dwosh, E., Butler, R., Leung, B., Fok, A., Rutherford, N.J. &#xa0;et al. (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain, 135, 709&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286328</ArticleId><ArticleId IdType="pubmed">22344582</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, L., Montrasio, F., Pattamatta, A., Tusi, S.K., Bardhi, O., Meyer, K.D., Hayes, L., Nakamura, K., Banez-Coronel, M., Coyne, A. &#xa0;et al. (2020) Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron, 105, 645&#x2013;662 e611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu, T., Guo, S., Bardhi, O., Ryskamp, D.A., Li, J., Khoramian Tusi, S., Engelbrecht, A., Klippel, K., Chakrabarty, P., Nguyen, L. &#xa0;et al. (2020) Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice. Proc. Natl. Acad. Sci. U. S. A., 117, 18591&#x2013;18599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414156</ArticleId><ArticleId IdType="pubmed">32690681</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, S., MacNair, L., McGoldrick, P., McKeever, P.M., McLean, J.R., Zhang, M., Keith, J., Zinman, L., Rogaeva, E. and Robertson, J. (2015) Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann. Neurol., 78, 568&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">26174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Laflamme, C., McKeever, P.M., Kumar, R., Schwartz, J., Kolahdouzan, M., Chen, C.X., You, Z., Benaliouad, F., Gileadi, O., McBride, H.M. &#xa0;et al. (2019) Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72. Elife, 8, e48363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794092</ArticleId><ArticleId IdType="pubmed">31612854</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti, Z. and Patten, S.A. (2018) RNA Dysregulation in amyotrophic lateral sclerosis. Front. Genet., 9, 712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio, M., Gonzales, P.K., Cook, C.N., Gendron, T.F., Daughrity, L.M., Song, Y., Ebbert, M.T.W., van &#xa0;Blitterswijk, M., Zhang, Y.J., Jansen-West, K. &#xa0;et al. (2017) Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients. Hum. Mol. Genet., 26, 3421&#x2013;3431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886204</ArticleId><ArticleId IdType="pubmed">28637276</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M. and Gingeras, T.R. (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics, 29, 15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray, N.L., Pimentel, H., Melsted, P. and Pachter, L. (2016) Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol., 34, 525&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">27043002</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz, Y., Wang, E.T., Airoldi, E.M. and Burge, C.B. (2010) Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods, 7, 1009&#x2013;1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037023</ArticleId><ArticleId IdType="pubmed">21057496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O'Keeffe, S., Phatnani, H.P., Guarnieri, P., Caneda, C., Ruderisch, N. &#xa0;et al. (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci., 34, 11929&#x2013;11947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince-Dunn, G., Okano, H.J., Jensen, K.B., Park, W.Y., Zhong, R., Ule, J., Mele, A., Fak, J.J., Yang, C., Zhang, C. &#xa0;et al. (2012) Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron, 75, 1067&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517991</ArticleId><ArticleId IdType="pubmed">22998874</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotti, M.M. and Swanson, M.S. (2016) RNA mis-splicing in disease. Nat. Rev. Genet., 17, 19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993438</ArticleId><ArticleId IdType="pubmed">26593421</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson, H. (2018) Repeat expansion diseases. Handb. Clin. Neurol., 147, 105&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485936</ArticleId><ArticleId IdType="pubmed">29325606</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusella, J.F. and MacDonald, M.E. (2000) Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci., 1, 109&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">11252773</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso, R., Olivan, S., Osta, R. and Navarro, X. (2011) Evolution of gait abnormalities in SOD1(G93A) transgenic mice. Brain Res., 1406, 65&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">21733494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooley, C.M., Sher, R.B., Kale, A., Frankel, W.N., Cox, G.A. and Seburn, K.L. (2005) Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve, 32, 43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1350398</ArticleId><ArticleId IdType="pubmed">15880561</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, J. and Cleveland, D.W. (2016) Bidirectional transcriptional inhibition as therapy for ALS/FTD caused by repeat expansion in C9orf72. Neuron, 92, 1160&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">28009271</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusella, J.F. and MacDonald, M.E. (2009) Huntington's disease: the case for genetic modifiers. Genome Med., 1, 80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768966</ArticleId><ArticleId IdType="pubmed">19725930</ArticleId></ArticleIdList></Reference><Reference><Citation>van &#xa0;Blitterswijk, M., Baker, M.C., DeJesus-Hernandez, M., Ghidoni, R., Benussi, L., Finger, E., Hsiung, G.Y., Kelley, B.J., Murray, M.E., Rutherford, N.J. &#xa0;et al. (2013) C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology, 81, 1332&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3806926</ArticleId><ArticleId IdType="pubmed">24027057</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin, A., Akimoto, C., Wuolikainen, A., Alstermark, H., Jonsson, P., Birve, A., Marklund, S.L., Graffmo, K.S., Forsberg, K., Brannstrom, T. &#xa0;et al. (2015) Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD. Hum. Mol. Genet., 24, 3133&#x2013;3142.</Citation><ArticleIdList><ArticleId IdType="pubmed">25712133</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandelot, E. and Gourdon, G. (2018) The flash-small-pool PCR: how to transform blotting and numerous hybridization steps into a simple denatured PCR. Biotechniques, 64, 262&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">29939093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes-Pereira, M., Bidichandani, S.I. and Monckton, D.G. (2004) Analysis of unstable triplet repeats using small-pool polymerase chain reaction. Methods Mol. Biol., 277, 61&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">15201449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne, C., Polymenidou, M. and Cleveland, D.W. (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet., 19, R46&#x2013;R64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada, M., Doi, H., Koyano, S., Kubota, S., Fukai, R., Hashiguchi, S., Hayashi, N., Kawamoto, Y., Kunii, M., Tanaka, K. &#xa0;et al. (2018) Matrin 3 is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am. J. Pathol., 188, 507&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">29128563</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, J.C., McGoldrick, P., Vance, C., Hortobagyi, T., Sreedharan, J., Rogelj, B., Tudor, E.L., Smith, B.N., Klasen, C., Miller, C.C. &#xa0;et al. (2013) Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol., 125, 273&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-de Groote, C., Van Broeckhoven, C. and Kumar-Singh, S. (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U. S. A., 107, 3858&#x2013;3863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik, A.M., Miguez, R.A., Li, X., Ho, Y.S., Feldman, E.L. and Barmada, S.J. (2018) Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife, 7, e35977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050042</ArticleId><ArticleId IdType="pubmed">30015619</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine, T.P., Daniels, R.D., Gatta, A.T., Wong, L.H. and Hayes, M.J. (2013) The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics, 29, 499&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570213</ArticleId><ArticleId IdType="pubmed">23329412</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif, M., Woehlbier, U. and Manque, P.A. (2017) The enigmatic role of C9ORF72 in autophagy. Front. Neurosci., 11, 442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5541066</ArticleId><ArticleId IdType="pubmed">28824365</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall, D. and Baloh, R.H. (2017) Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Invest., 127, 3250&#x2013;3258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao, Q., Liang, C., Chang, Q., Zhang, W., Yang, M. and Chen, J.F. (2019) C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta Neuropathol. Commun., 7, 32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398253</ArticleId><ArticleId IdType="pubmed">30832726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes, L.R. and Rothstein, J.D. (2016) C9ORF72-ALS/FTD: transgenic mice make a come-BAC. Neuron, 90, 427&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7045171</ArticleId><ArticleId IdType="pubmed">27151634</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy, K., Zamiri, B., Stanley, S.Y., Macgregor, R.B., Jr. and Pearson, C.E. (2013) The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem., 288, 9860&#x2013;9866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, Y., Mori, E., Kato, M., Xiang, S., Wu, L., Kwon, I. and McKnight, S.L. (2016) Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell, 167, 789&#x2013;802.e712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, K.H., Zhang, P., Kim, H.J., Mitrea, D.M., Sarkar, M., Freibaum, B.D., Cika, J., Coughlin, M., Messing, J., Molliex, A. &#xa0;et al. (2016) C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell, 167, 774&#x2013;788.e717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain, A. and Vale, R.D. (2017) RNA phase transitions in repeat expansion disorders. Nature, 546, 243&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5555642</ArticleId><ArticleId IdType="pubmed">28562589</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis, J., Hart, M.P., Shorter, J., DeJesus-Hernandez, M., Erion, R., Oristano, R., Liu, A.X., Ramos, D., Jethava, N., Hosangadi, D. &#xa0;et al. (2011) A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. U. S. A., 108, 20881&#x2013;20890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin, S.Y., Lopez-Gonzalez, R., Kunz, R.C., Gangopadhyay, J., Borufka, C., Gygi, S.P., Gao, F.B. and Reed, R. (2017) Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause Mis-splicing in ALS/FTD patients. Cell Rep., 19, 2244&#x2013;2256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, I., Xiang, S., Kato, M., Wu, L., Theodoropoulos, P., Wang, T., Kim, J., Yun, J., Xie, Y. and McKnight, S.L. (2014) Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science, 345, 1139&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, K.Y., Mori, E., Nizami, Z.F., Lin, Y., Kato, M., Xiang, S., Wu, L.C., Ding, M., Yu, Y., Gall, J.G. &#xa0;et al. (2017) Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc. Natl. Acad. Sci. U. S. A., 114, E1111&#x2013;E1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter, D.S.W. and Parker, R. (2016) Principles and properties of stress granules. Trends Cell Biol., 26, 668&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4993645</ArticleId><ArticleId IdType="pubmed">27289443</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen, J.C., Erdin, S., Chiang, C., Hanscom, C., Handley, R.R., Barker, D.D., Stortchevoi, A., Blumenthal, I., Reid, S.J., Snell, R.G. &#xa0;et al. (2017) Potential molecular consequences of transgene integration: the R6/2 mouse example. Sci. Rep., 7, 41120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5264158</ArticleId><ArticleId IdType="pubmed">28120936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, L., Laboissonniere, L.A., Guo, S., Pilotto, F., Scheidegger, O., Oestmann, A., Hammond, J.W., Li, H., Hyysalo, A., Peltola, R. &#xa0;et al. (2020) Survival and motor phenotypes in FVB C9-500 ALS/FTD BAC transgenic mice reproduced by multiple labs. Neuron, 108, 784&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8281452</ArticleId><ArticleId IdType="pubmed">33022226</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, M. (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal, 17, 10&#x2013;12.</Citation></Reference><Reference><Citation>Marco-Sola, S., Sammeth, M., Guigo, R. and Ribeca, P. (2012) The GEM mapper: fast, accurate and versatile alignment by filtration. Nat. Methods, 9, 1185&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">23103880</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. (2013) Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv:1303.3997v1 [q-bio.GN], in press.</Citation></Reference><Reference><Citation>
Picard . A set of command line tools (in java) for manipulating high-throughput sequencing (HTS) data and formats such as SAM/BAM/CRAM and VCF. http://picard.sourceforge.net. in press.</Citation></Reference><Reference><Citation>McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M. and DePristo, M.A. (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res., 20, 1297&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2928508</ArticleId><ArticleId IdType="pubmed">20644199</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>